The Effects of Behavioral Counseling Plus Nicotine Replacement Therapy (NRT) or Varenicline on Smoking Cessation Among Smokers High and Low in Intrinsic Reward Sensitivity
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 11 Apr 2019
Price : $35 *
At a glance
- Drugs Varenicline (Primary) ; Nicotine
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 29 Jan 2018 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 29 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 14 Dec 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.